Smith & Nephew plc (SNNUF)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
As of 12:58PM EDT. Market open.
| Previous close | 15.45 |
| Open | 15.45 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 15.45 - 15.45 |
| 52-week range | 14.52 - 22.64 |
| Volume | |
| Avg. volume | 800 |
| Market cap | 14.268B |
| Beta (5Y monthly) | 0.45 |
| PE ratio (TTM) | 24.52 |
| EPS (TTM) | 0.63 |
| Earnings date | N/A |
| Forward dividend & yield | 0.38 (2.43%) |
| Ex-dividend date | 31 Mar 2022 |
| 1y target est | N/A |
- Simply Wall St.
Smith & Nephew (LON:SN.) stock falls 5.1% in past week as three-year earnings and shareholder returns continue downward trend
For many investors, the main point of stock picking is to generate higher returns than the overall market. But the risk...
- Stockopedia
Will the Smith amp; Nephew share price run continue?
In this article we will quickly re-cap the broker forecasts for Smith amp;amp; Nephew (LON:SN.). The Smith amp;amp; Nephew share price has risen by 1.46% ove...
- The Telegraph
Questor: Smith & Nephew may look expensive at a p/e of 29 but the figure is deceptive
The absence of any nasty surprises, after a couple of disappointing updates in 2021, represents a good start to 2022 for Smith & Nephew and this column continues to believe that the orthopaedics, wound care and sports medicine specialist could yet be a beneficiary of anything like a return to normality in hospitals as and when the pandemic finally wanes.
© 2022 Yahoo. All rights reserved.
